Table 5.
Pre |
Post |
Two-week follow-up |
Three-month follow-up |
F | p | Partial η2 | Multiple comparison | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
M | SD | M | SD | M | SD | M | SD | |||||
HAMD17 | 17.5 | 5.2 | 4.1 | 4.5 | 5.0 | 5.0 | 5.9 | 7.3 | 46.50 | <0.001 | 0.69 | Pre > post, two-week, three-month |
BDI-II | 29.1 | 9.3 | 15.9 | 11.4 | 15.7 | 11.4 | 14.6 | 12.2 | 24.02 | 0.53 | ||
GAD-7 | 12.2 | 5.3 | 6.4 | 5.0 | 6.8 | 5.3 | 6.5 | 5.4 | 22.11 | 0.51 | ||
FACT-G | ||||||||||||
Physical | 13.1 | 6.2 | 17.4 | 8.4 | 18.0 | 7.8 | 18.9 | 7.9 | 10.91 | <0.001 | 0.34 | Pre < post, two-week, three-month |
Social/Family | 13.2 | 6.6 | 16.2 | 6.5 | 13.7 | 7.7 | 15.9 | 6.8 | 3.75 | 0.015 | 0.15 | Pre < post, three-month |
Emotional | 8.3 | 5.1 | 13.1 | 5.7 | 13.8 | 5.5 | 13.5 | 5.3 | 18.98 | <0.001 | 0.48 | Pre < post, two-week, three-month |
Functional | 8.7 | 3.6 | 14.5 | 5.2 | 13.8 | 4.8 | 15.4 | 5.9 | 24.18 | 0.54 | ||
Total | 43.2 | 13.1 | 61.1 | 19.8 | 59.2 | 19.8 | 63.7 | 20.8 | 20.31 | 0.49 | ||
VQ Obstruction | 15.3 | 4.4 | 15.0 | 5.1 | 14.6 | 4.8 | 14.3 | 5.2 | 0.42 | 0.738 | 0.02 | — |
BADS-SF | ||||||||||||
Activation | 6.4 | 3.3 | 12.3 | 5.1 | 12.0 | 5.7 | 11.7 | 6.1 | 12.13 | <0.001 | 0.37 | Pre < post, two-week, three-month |
Avoidancea | 12.7 | 3.4 | 14.9 | 3.5 | 14.2 | 3.4 | 14.6 | 3.1 | 6.45 | 0.24 | ||
Total | 19.1 | 5.1 | 27.2 | 6.6 | 26.2 | 7.8 | 26.3 | 7.7 | 15.54 | 0.43 | ||
RPI Environmental Suppressorsa | 22.5 | 4.0 | 24.6 | 3.8 | 25.1 | 4.2 | 25.9 | 4.0 | 6.94 | 0.25 |
Reverse-scaled items.